Insmed reported $10.32M in Interest Expense on Debt for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Acelrx Pharmaceuticals ACRX:US $ 614K 58K
Alexion Pharmaceuticals ALXN:US $ 27.1M 0.6M
Arena Pharmaceuticals ARNA:US $ 1.05M 0.02M
Biomarin Pharmaceutical BMRN:US $ 3.82M 0.01M
Cytokinetics CYTK:US $ 4.07M 0.08M
Dynavax Technologies DVAX:US $ 3.11M 1.6M
Flexion Therapeutics FLXN:US $ 5.18M 9K
Gilead Sciences GILD:US $ 256M 1M
Insmed INSM:US $ 10.32M 2.76M
Novartis NVS:US $ 201M 1M
Regeneron Pharmaceuticals REGN:US $ 14.4M 0.2M
Sarepta Therapeutics SRPT:US $ 15.83M 0.18M
Vertex Pharmaceuticals VRTX:US $ 15.48M 0.2M